The “grey zone” between neuromyelitis optica spectrum disorders (NMOSD) and MS remains a diagnostic challenge for clinicians. According to a study of almost 300 cases of suspected demyelinating disease from 23 adult and paediatric CNS clinics in Australia and New Zealand, a relatively high proportion were found to be suspected NMOSD but negative for aquaporin-4 ...
NMOSD vs MS diagnosis remains a grey zone
By Mardi Chapman
6 Feb 2020